-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis.
OBESITY IS ASSOCIATED WITH chronic, low-grade inflammation characterized by a rise in circulating inflammatory cytokines and infiltration of tissues by innate immune cells (48, 50) . Inflammation is increasingly being related to complications of obesity like insulin resistance and atherosclerosis but the underlying mechanisms and therapeutic potential remain unclear (14) . Muscle and adipose tissue from obese humans show an elevated presence of immune cells (18) that originate from the bone marrow and cross the endothelial layer of capillaries and venules to reach the tissues where they differentiate into macrophages (19) . Monocyte chemoattractant protein-1 (MCP1) and other chemokines, as well as nucleotides are recognized chemoattractants for monocytes in obesityassociated inflammation (36) , but the infiltration of immune cells requires expression of adhesion molecules at the surface of endothelial cells to promote their adhesion and transmigration. This interaction is carried out at the microvascular endothelium, by members of the immunoglobulin superfamily (intercellular adhesion molecules ICAM-1, ICAM-2, ICAM-3, and vascular cell adhesion molecule VCAM-1) and selectins (E and P) that recognize their cognate ligands on the leukocyte surface. Although the process of adhesion, rolling, and transmigration of leukocytes has been well described (40) , the status of immune cell transmigration in obesogenic environments is unclear (39) .
Microvascular blood vessels are structurally and functionally distinct from those in larger vessels (1) . Large arteries regulate blood flow and its distribution, whereas capillaries and post-capillary venules supply muscle fibers and adipose cells with insulin and nutrients and are the favored site for immune cell transmigration (51) . While fatty acid-induced inflammation in cells from macrovessels such as umbilical vein (HUVEC) or aorta (HAEC) is recognized (22, 49) , essentially nothing is known about the effects of a high-fat environment on human microvascular endothelia, especially on cells from relevant metabolic tissue beds such as skeletal muscle or adipose tissue.
In parallel to provoking inflammation, high-fat feeding causes insulin resistance (42) . Saturated fatty acids are major contributors to this process, as they directly impair insulin sensitivity in adipocytes and muscle cells in culture through lipotoxic and proinflammatory effects (6) . In vivo, however, the regulation of insulin sensitivity involves complex integrated responses involving multi-organ cross-talk. In particular, and often underestimated, is the contribution of the microvasculature to insulin resistance, by regulating the delivery of insulin to its target organs (26) , specifically to muscle and adipose tissue. Several studies suggest that insulin delivery to tissues is a critical determinant of insulin-mediated glucose uptake, since insulin injected intravenously equilibrates rapidly within plasma but only slowly within the skeletal muscle interstitium (13) . Indeed, following an intravenous insulin injection, the time course of insulin-dependent Akt phosphorylation in muscle parallels the rise in interstitial insulin but not that of plasma insulin, revealing that the microvascular endothelium is a rate-limiting step in insulin action (26) . Moreover, the access of insulin to its target tissues is markedly diminished in high-fat-fed dogs (16, 27) and in diabetic humans (47) , suggesting that endothelial cells play a crucial role in regulating insulin-induced glucose uptake. The delivery of proteins across the microvascular endothelium can in principle occur between (paracellular) or through (transcytosis) endothelial cells (3) . Importantly the endothelium lining the microvasculature of muscle and adipose tissue is continuous in nature, with circumferential tight junctions and no gaps between cells. Accordingly, we recently demonstrated that insulin crosses a confluent monolayer of human adipose microvascular endothelial cells (HAMEC) specifically by transcytosis, involving endocytosis via clathrin-coated pits (4) . However, it is unknown whether and how saturated fatty acids and inflammation affect this process.
Here, we explore whether saturated or unsaturated fatty acids activate a proinflammatory response in HAMEC and its possible consequences on two major endothelial cell functions: monocyte adhesion and insulin transcytosis. Strikingly, whereas palmitate treatment increased monocyte adhesion and transmigration across HAMEC, it reduced insulin transcytosis. Potentially, these responses to saturated fat environments could contribute to elevated immune cell infiltration and reduced insulin delivery to muscle and fat tissues during obesity.
METHODS
Reagents. Sulfo-N-succinimidyl oleate (SSO) and cardamonin were from Cedarlane (Burlington, ON, Canada) and TAK242 from Millipore (Etobicoke, ON, Canada). Neutralizing antibody for intercellular adhesion molecule 1 (ICAM-1; CD54, BBA4) was from R&D Systems (Minneapolis, MN). All other chemicals were from SigmaAldrich (St. Louis, MO). siRNA oligonucleotides against Toll-like receptor 4 (TLR4) were purchased from Life Technologies (Burlington, ON, Canada), siRNA for ICAM-1, E-selectin (SELE), and MYD88 were purchased from Qiagen (Valencia, CA).
Palmitate preparation. Palmitate or palmitoleate (P9767 and P9417, Sigma-Aldrich) stock solutions (200 mM) were prepared in 50% ethanol by heating at 50°C. Fatty acid-free, low-endotoxin BSA (A8806, Sigma-Aldrich) was dissolved in serum-free ␣-MEM to 10.5%. Fatty acid stocks were diluted 25ϫ in the BSA solution and conjugated under agitation at 40°C for 2 h. This solution (lipid/BSA ratio 5:1) was further diluted in culture medium. Palmitate and palmitoleate solutions thus coupled to BSA are denoted as PA and PO, respectively.
Cell culture, viability. HAMEC were purchased from ScienCell (Carlsbad, CA). Primary human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC) were purchased from Lonza (Allendale, NJ). Endothelial cells were cultured in EGM-MV medium (Lonza, Allendale, NJ) in an incubator at 37°C and 5% CO2. Only cells from passages 4 -9 were used. L6 muscle cells were maintained in ␣-MEM supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, and 10% fetal bovine serum. Differentiation was induced by switching confluent cells to ␣-MEM with 2% FBS for 4 -5 days. Cellular viability was assessed from Trypan blue uptake and LDH activity (Cytotoxicity Detection Kit; Roche Applied Science, Indianapolis, IN).
siRNA transfection. HAMEC were seeded at 60% confluence, and transfection of siRNA was performed using Lipofectamine RNAiMax reagent according to the manufacturer's protocol with slight modification. In brief, 24 h after seeding, cells were transfected with 100 nM siRNA for 5 h and then changed to regular medium for 24 h followed by a second round of siRNA transfection. Cells were used for experiments 24 h thereafter, and knockdown was compared with scramble siRNA sequences.
RNA isolation and qPCR. All reagents were from Life Technologies (Carlsbad, CA). RNA was isolated using TRIzol and cDNA synthesized using the SuperScript VILO cDNA kit. Ten nanograms per reaction was used for RT-qPCR using predesigned Taqman probes. HPRT1 and ABT1 expression was not affected by any of the treatments, and they were therefore considered to be suitable housekeeping genes. qPCR were performed for 40 cycles (95°C for 1 s, 60°C for 20 s), and the relative quantities of each mRNA were calculated using the comparative ⌬⌬C T method.
Fatty acid uptake. To calculate disappearance of fatty acids from the medium, nonesterified fatty acids were quantified in the media of fatty acid-incubated myotubes by use of the NEFA-HR kit (Wako Chemical, Richmond, VA). Briefly, cells were seeded in a 96-well plate, L6 were differentiated as described above, and HAMEC were grown to confluence. Cells were treated in 100 l of medium supplemented with fatty acids for 18 h. Uptake was indirectly estimated from the fatty acid content in the supernatant at the beginning and end of the incubation.
Uptake of radiolabeled palmitate was also used to measure rates of fatty acid uptake. [ 14 C]palmitate was prepared in 10% BSA (2.6 Ci in 162 l BSA) and dissolved 1:40 in ␣-MEM supplemented with 2% FBS. Cells seeded in 12-well plates were treated with 500 l (0.2 Ci/well) for 0.5, 1, 2, and 4 h. Cells were washed with ␣-MEM-FBS and then with PBS, detached using 500 l of trypsin, and transferred into glass tubes containing 3 ml of methanol-chloroform (2:1). Lipids were extracted by adding 1 ml of chloroform and 1 ml of NaCl (1 M), 30 s of vortex agitation, and centrifugation (1,500 rpm for 10 min). The lower layer containing the lipids was transferred into a glass tube, solvents were evaporated under nitrogen, and residue was reconstituted in 2 ml of chloroform. Radioactivity was counted in 200 l of this extract by use of a Packard TRI-CARB 2900TR liquid scintillation counter (Packard, Meriden, CT) with a detector efficiency of 45.81%. Radioactivity is expressed as nCi/mg protein.
Cell metabolism analysis. Oxygen consumption rate (OCR) was measured using a Seahorse XF e 96 analyzer (Seahorse Bioscience, Billerica, MA). L6 and HAMEC grown in Seahorse 96-well cell culture plates were differentiated as described above and then equilibrated for 1 h in XF Base Medium supplemented with 1 mM glucose and 0.2 mM fatty acids. Baseline measurements were performed for 1 h, and then oligomycin (1 M, 20 min) and FCCP (1 M, 20 min) were added sequentially, followed by rotenone and antimycin A (1 M, 20 min).
Immunohistochemistry. HAMEC were grown to confluent monolayer and then treated for 18 h with 0.2 mM PA, PO, or the BSA vehicle. Cells were washed with PBS, fixed in 4% PFA for 20 min on ice, quenched with 0.1 M glycine for 10 min, and then blocked with 3% BSA for 30 min at room temperature. Cell surface ICAM-1 was detected with mouse anti-ICAM-1 antibody (1:100, R&D Systems) and donkey anti-mouse antibody conjugated to Cy3 (1:1,000; Jackson ImmunoResearch Laboratories, West Grove, PA). Fluorescence images were taken with a Leica spinning-disk confocal microscope using Volocity software (PerkinElmer, Waltham, MA). Each field was quantified by ImageJ software (NIH, Bethesda, MD).
Monocyte adhesion assay. HAMEC grown in 96-well plates until confluence were treated with fatty acids for 18 h. THP1 monocytes (10 6 cells/ml) were prestimulated with LPS (200 ng/ml for 3 h) and loaded with calcein (2 g/ml for 30 min). Monocytes were then washed with PBS and suspended in endothelial media at 10 6 cells/ml, and 100 l was added on top of endothelial cells. The plate was incubated for 45 min at 37°C and then washed three times with PBS, and fluorescence was measured using a microplate reader (excitation/ emission: 495/515 nm).
Monocyte transmigration assay. HAMEC were grown to confluence onto transwells (6.5 mm in diameter, 8 m pore, Costar). The monolayer was then treated with BSA or 0.2 mM PA or PO in serum-free culture medium for 18 h. For the chemotaxis assay, 1 ϫ 10 6 THP-1 cells/ml were incubated with 200 ng/ml LPS at 37°C for 3 h and then washed with PBS and resuspended in RPMI 1640. 1 ϫ 10 5 THP-1 cells in 100 l of RPMI 1640 were added to the upper chamber, and 600 l of RPMI 1640 with or without 10 M ATP was added to the lower chamber. The assembly was incubated at 37°C, 5% CO 2 for 3 h. THP-1 cells migrating into the lower chamber were counted manually using a hemocytometer.
Total internal reflection fluorescence microscopy. Visualization of insulin arriving at the ventral membrane was performed by total internal reflection fluorescence microscopy (TIRF) microscopy using a method developed by our laboratories (4). Briefly, HAMEC were treated with 500 nM Alexa fluor 568-conjugated insulin for 10 min at 4°C to allow insulin to bind to its receptor, but prevent internalization. Excess insulin was then washed off with PBS. Samples were then imaged using a ϫ150/1.45NA objective on a heated stand (37°C) in RPMI 1640 media supplemented with HEPES buffer using an Olympus cell TIRF motorized multicolor module mounted on an Olympus IX81 microscope (Olympus, Hamburg, Germany). Images (150 per cell) were taken at 10 FPS. Transcytosis events were quantified in an automated and blinded fashion using custom-written matlab scripts, as described in Ref. 4 . Briefly, fluorescent insulin-laden vesicles were identified using a local background subtraction followed by binary thresholding. The movement of individual vesicles was tracked frameto-frame, and those undergoing fusion were identified by detection of vesicles displaying highly confined movement ("docked" vesicles) (9) and which underwent a rapid decrease in fluorescence over the final frames of the vesicle track.
Insulin uptake. HAMEC were seeded onto glass coverslips and allowed to grow to confluence. Cells were incubated with 50 nM FITC-tagged insulin (I3661, Sigma) for 15 min at 37°C to allow insulin to internalize, as reported earlier (4). Cells were then washed with PBS to remove noninternalized insulin and fixed with 4% PFA for 20 min. Remaining PFA was quenched with 0.3 M glycine for 10 min. Nuclei were stained with DAPI for 10 min. Coverslips were covered with fluorescent mounting medium (Dako, Carpinteria, CA) supplemented with DAPI (1 g/ml) and imaged using an Olympus IX81 spinning disc confocal microscope with a ϫ60/1.35 NA oil immersion objective with settings kept constant between conditions. Fluorescence intensity was assessed by ImageJ (NIH, Bethesda, MD).
Transwell assay of insulin transcytosis. HAMEC were grown to confluence on 12-well transwells with a membrane pore size of 0.4 m (Costar 3460, Corning, NY). Cells were incubated with 500 nM biotinylated insulin (I2258, Sigma) at 4°C for 10 min to allow binding to the cell surface but not internalization. Unbound insulin was Potential cytotoxicity caused by fatty acid treatment was estimated through Trypan blue uptake and LDH release after exposing primary endothelial cells from human adipose tissue microvasculature (HAMEC) to 0.2 mM BSA, palmitate (PA), and palmitoleate (PO) for 18 h. LDH results are normalized to the total LDH released after lysing the cells with 0.1 % Triton X-100. Results are expressed as means Ϯ SD; n Ն 3. , and aorta (HAEC; E and F) were exposed to 0.2 mM palmitate (PA), palmitoleate (PO), or BSA vehicle for 18 h. Gene expression of inflammatory cytokines and immune receptors was measured by RT-qPCR as described in METHODS and normalized to BSA-treated cells.
HAMEC
Results are means Ϯ SE; n Ն 4. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. BSA control.
washed off with PBS, and then medium at 37°C was added to the transwells to initiate insulin internalization. After 30 min, the bottom chamber was sampled using ELISA for biotinylated-insulin. Briefly, samples were incubated on a streptavidin-coated plate for 1 h (Life Technologies, Carlsbad, CA (2 M) . Optical density at 450 nm was determined with a spectrophotometric plate reader. Statistical analysis. Analyses were performed using Prism software (GraphPad Software, San Diego, CA). The effects of inhibitors were analyzed by two-way ANOVA, followed by adequate Sidak post hoc tests. One-way ANOVA was used to test differences between groups with equal variances. Statistical significance was set at P Ͻ 0.05.
RESULTS
Palmitic acid is the most abundant saturated fatty acid in the Western diet and a major constituent of the blood nonesterified fatty acids (38) . The total free fatty acid concentration in serum can reach 0.8 mM in obese individuals, of which roughly 25% is palmitate (45, 52) . We consequently used 0.2 mM as a physiological concentration to treat HAMEC in vitro that would emulate endothelial exposure to fatty acid exposure in vivo.
The fatty acid stock solutions contain 8 mM fatty acids and 1.6 mM BSA, while the culture medium (5% fetal bovine serum) contains ϳ0.06 mM albumin. After dilution (40-fold), the final molar ratio fatty acid to total albumin in the culture medium is 3:1. This ratio does not surpass the binding capacity of albumin, as each molecule of albumin contains six highenergy binding sites for fatty acids (43) , and it helps reduce the amount of residual fatty acid-free BSA that may have nonspecific effects such as depleting cholesterol from membranes (34) . At this concentration and ratio, neither palmitate, palmitoleate, nor BSA affected LDH release or Trypan blue uptake by HAMEC (Table 1) .
Palmitate, but not palmitoleate, activates a proinflammatory response in microvascular endothelial cells. Saturated fatty acids can activate proinflammatory pathways in immune and nonimmune cells, leading to the expression and release of cytokines and chemokines (17) . Overnight exposure (18 h) of HAMEC to the saturated fatty acid PA, but not to the monounsaturated PO, induced gene expression of the proinflammatory cytokines IL6 and IL8 (Fig. 1A) and of the immune receptor TLR2 (Fig. 1B) . A qualitatively similar response was also observed in endothelial cells from large vessels, HUVEC and HAEC (Fig. 1, C-F) , consistent with a number of previous reports (35, 49) . These data demonstrate that endothelial cells, including those derived from microvessels, can activate proinflammatory pathways in response to palmitate.
Palmitate induces expression of adhesion molecules in microvascular endothelial cells. In response to infection or tissue damage in vivo, the endothelial proinflammatory response involves activation and recruitment of circulating immune cells. This occurs through the expression of adhesion molecules at the luminal side of endothelial cells, inducing leukocyte rolling and eventually diapedesis (40) . In HAMEC, PA treatment brought about an increase in mRNA expression of SELE (3-fold) and ICAM-1 (3.5-fold) (Fig. 2A) . Conversely, PA reduced the expression of platelet endothelial cell adhesion molecule 1 (PECAM-1), whereas no change was detected in HAMEC or L6 myotubes were treated with 0.2 mM PA, PO, or BSA vehicle for 18 h. Fatty acid content in the supernatant was measured before (initial) and after (final) incubation as described in METHODS. Data are means Ϯ SE; n ϭ 4. ***P Ͻ 0.001 vs. control, ns, not significant. C: uptake of [ 14 C]palmitate was measured over 4 h as described in METHODS. Data are means Ϯ SE, n ϭ 2. D and E: oxygen consumption rate (OCR) was measured using a Seahorse XF e 96 analyzer as described in METHODS. A representative plot (D) and quantification of the OCR in response to oligomycin are shown (E, n ϭ 2). F: PA uptake is reduced in L6 myotubes in the presence of the CD36 inhibitor sulfo-N-succinimidyl oleate (SSO, 200 M). PA content in the supernatant before and after incubation was measured as described in METHODS. Data are means Ϯ SE, n ϭ 3, *P Ͻ 0.05. G-J: HAMEC were treated with 0.2 mM PA or BSA vehicle for 18 h in the presence of CD36 inhibitor SSO (200 M). Gene expression was measured by RT-qPCR and normalized to BSA control. Results are means Ϯ SE; n Ն 4. *P Ͻ 0.05, ***P Ͻ 0.001 vs. control.
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, and VE-cadherin. By immunoblotting, a significant increase in total cellular ICAM-1 protein, but not SELE, was observed in PA-treated cells (Fig. 2, B and  C) . To promote adhesion of immune cells, ICAM-1 and/or SELE have to be exposed at the plasma membrane. Using antibodies directed to the extracellular part of ICAM-1 or SELE, we examined the localization of these proteins in nonpermeabilized cells by confocal fluorescence microscopy. Interestingly, only ICAM-1 was significantly elevated at the plasma membrane in response to PA (Fig. 2D) . The exclusive localization of ICAM-1 at the apical membrane of HAMEC verifies the polarity of the cell monolayer and the endothelial phenotype of HAMEC cultures. On the other hand, and consistent with the immunoblotting results, SELE detection by immunofluorescence did not increase with PA, and in fact it was detected in only a small number of cells and was not clearly at the cell surface, even when two distinct antibodies were used (data not shown). In contrast, LPS increased the amount of SELE at the surface of HAMEC, indicating that the antibodies used are reliable for immunofluorescence. Hence, although PA increases SELE mRNA levels, these do not translate into frank protein elevation within the time frame analyzed in the majority of the cells in the monolayer.
Gene expression of adhesion molecules requires TLR4¡NF-B signaling but not PA uptake. Many of the deleterious effects of fatty acids have been ascribed to impairment of metabolism due to an overload of nutrient entering cells through CD36 (32) . However, the concentration of fatty acids in the supernatant from HAMEC did not change before and after exposure to either PA or PO (Fig. 3A) . By comparison, L6 myotubes cultured under the same conditions reduced the fatty acid concentration in the medium by ϳ55% (Fig. 3B) . This differential rate of fatty uptake was confirmed using radiolabeled [ 14 C]palmitate. Over 4 h, HAMEC exhibited a significantly lower rate of [ 14 C]palmitate uptake compared with muscle cells (Fig. 3C ). In addition, HAMEC had a very low OCR even when incubated with 0.2 mM PA or PO (Fig.  3D) . Moreover, the addition of oligomycin (an inhibitor of the ATP synthase) did not significantly reduce the OCR in HAMEC (Fig. 3E) , suggesting that these cells scarcely oxidize fatty acids to produce energy. Collectively, these observations reveal that HAMEC neither accumulate nor utilize a significant amount of fatty acids, and therefore the PA-induced proinflammatory response may be independent of its metabolic effects in these cells. To further confirm the independence of the HAMEC response to PA from fatty acid uptake, cells were incubated with PA in the presence of SSO, a potent CD36 inhibitor (29) . SSO significantly prevented the depletion of fatty acids in the supernatant of L6 myotubes (Fig. 3F ) but did not affect the PA-induced gene expression of SELE and ICAM-1 (Fig. 3, G and H) or of the cytokines IL-6 and IL-8 in HAMEC (Fig. 3, I and J) .
The independence of the PA response of HAMEC from fatty acid uptake suggested that the fatty acid may be sensed by pathways unrelated to its metabolism. It has been proposed that fatty acids can act on TLRs, leading to activation of the NF-B transcription factor (41) . TLR4 can be selectively inhibited by TAK242 (23) , while cardamonin prevents IKK phosphorylation and the consequent NF-B activation (21) . We verified that TAK242 and cardamonin act accordingly in HAMEC, as these inhibitors eliminated the induction of cytokines and adhesion molecules provoked by the canonical TLR4 agonist LPS (data not shown). The increase in ICAM-1 and SELE expression in response to PA was significantly blunted by TAK242 and cardamonin (Fig. 4, A and B) . This result suggests that the TLR4¡NF-B pathway is required for the inflammatory response of HAMEC to PA.
PA increased monocyte adhesion and transmigration. Elevated ICAM-1 at the surface of endothelial cells would be expected to promote immune cell adhesion and transmigration. Indeed, PA increased the adhesion of human THP1 monocytes to PA-treated HAMEC compared with BSA-and PO-treated cells (Fig. 5A) . In good agreement with this finding, PA also promoted the transmigration of monocytes toward the chemoattractant ATP across a HAMEC monolayer in transwell assays (Fig. 5B) . Mechanistically, the PA-induced monocyte adhesion was likely mediated by the rise in surface levels of ICAM-1, since it was reduced by neutralizing antibodies against this adhesion molecule (Fig. 5C ). While these results clearly show that PA did not promote monocyte adhesion in the presence of the neutralizing anti-ICAM-1 antibody (compared with neutralization in BSA-treated cells), the antibody alone unexpectedly increased monocyte adhesion in both PA-and BSA-treated cells. Therefore, as a complementary approach to determine ICAM-1 participation, we used siRNAs to efficiently reduce the levels of ICAM-1 and SELE (Fig. 5D) . Silencing of ICAM-1, but not SELE, prevented the PA-induced monocyte adhesion (Fig. 5E ).
TLRs couple with adaptor MyD88 to activate the NF-B transcription factor, and interestingly, silencing of MyD88 also prevented the PA-induced monocyte adhesion (Fig.  5F ). Furthermore, inhibition of the TLR4¡NF-B pathway by TAK242 or cardamonin blunted the increase in monocyte adhesion to HAMEC induced by PA (Fig. 5G) , consistent with the prevention of ICAM expression observed with these inhibitors. All together, these findings indicate that PA provokes activation of the TLR4¡NF-B pathway in HAMEC, and the consequent expression of ICAM-1 to promote monocyte adhesion and transmigration.
Palmitate impairs insulin transcytosis. As mentioned in the introductory section, local and systemic inflammation is associated with obesity-induced insulin resistance in vivo, and obesity also impairs insulin delivery to metabolic tissues. We therefore examined the possibility that the PA-induced activa- tion of inflammatory pathways in HAMEC might compromise insulin transcytosis. To this end we used our recently developed assay of insulin transcytosis using TIRF microscopy to detect insulin exocytic events in HAMEC that had first been allowed to internalize Alexa fluor 568-conjugated insulin (4). Notably, transcytosis of fluorescent insulin across HAMEC was significantly reduced by PA, but not by PO, relative to transcytosis in BSA-containing medium (Fig. 6A) . This was also confirmed in a transwell assay where PA decreased the transfer of insulin across a confluent monolayer of HAMEC (Fig. 6B) . In this case, we also implemented an insulin-binding step at the apical membrane prior to assessing the endothelial monolayer's permeability to the hormone. The membranebinding step decreases any confounding by diffusion of insulin across paracellular gaps and means that measured permeability preferentially reflects the contribution of transcytosis (3). The observed decrease in insulin transcytosis across HAMEC caused by PA could be due to either a defect in transit or a reduction in the uptake of insulin. Uptake of fluorescent insulin by HAMEC was partly but significantly reduced by PA compared with PO or the BSA control (Fig. 6C) . These results reveal that PA treatment reduces insulin uptake but do not rule out a potential effect of PA to curtail insulin exit from HAMEC. Interestingly, the reduction in insulin transcytosis provoked by PA was no longer observed in HAMEC incubated in the presence of the TLR4 inhibitor TAK242 (Fig. 6D) or when TLR4 was knocked down using cognate siRNA oligomers (Fig. 6E) . It must be noted that TAK242 on its own decreased insulin transcytosis; however, the loss of effect of PA was confirmed in the TLR4 knockdown experiments, supporting the concept that TLR4 mediates the PA-induced reduction in insulin transcytosis. Collectively, the results in Fig. 6 demonstrate that, in addition to promoting monocyte adhesion, activation of proinflammatory pathways by PA also reduces insulin transcytosis.
DISCUSSION
High-fat feeding in mice and obesity in humans leads to insulin resistance and promotes infiltration of blood-derived immune cells in the adipose tissue and skeletal muscle. Although these two defects suggest involvement of the microvasculature, it is difficult to dissect the particular role of microvascular endothelial cells in vivo due to the diversity of cells coexisting within metabolic tissues and the heterogeneous nature of the endothelium itself. Since endothelial cells from different tissues exhibit significantly different phenotypic and functional characteristics (1), it is essential to choose the most appropriate model to study physiological responses appropriately. Both monocyte diapedesis and insulin transcytosis occur in the microvasculature, and adipose tissue is a major contributor to the regulation of insulin sensitivity and glucose uptake. In this regard, HAMEC are a superior model compared with cells from the aorta or the umbilical vein to study the delivery of cells and molecules to the parenchyma of metabolic tissues. Using this cell culture paradigm, we demonstrate that micro- vascular endothelial cells mount a proinflammatory response to saturated fatty acids that affects two of their major functions: monocyte transmigration and insulin transcytosis. Deleterious effects of saturated fatty acids have been described in many different cell types (25) . Long-term exposure to high concentrations of saturated fatty acids have previously been found to trigger apoptosis in cells in culture. In endothelial cells, most studies on viability and lipotoxic effects of palmitate used exposure of more than 24 h and doses more than 0.3 mM often with a high palmitate/BSA ratio (24, 30, 44, 53) . Moreover, the apoptosis induced by high concentrations of PA in aortic cells is independent of NF-B activation, dissociating the proinflammatory effects of saturated fatty acids from their toxicity at high concentrations (12) . In our hands, 0.2 mM PA for 18 h did not induce any toxicity, as evinced by the lack of LDH release and uptake of Trypan blue, demonstrating that the increased monocyte adhesion and impaired insulin transcytosis observed are not due to nonspecific cell toxicity.
Utilization of fatty acids by the mitochondria and the associated production of reactive oxygen species can be damaging to cells through activation of stress and inflammatory pathways (5) . In addition, fatty acid metabolites such as diacylglycerol and ceramides can induce perturbations in metabolism and contribute to insulin resistance in metabolic tissues (46) . Fatty acids can also be incorporated in other cellular lipids that accumulate in membranes or lipid droplets (2) . In contrast to those findings in tissues that actively metabolize fatty acids, we found that HAMEC do not take in or oxidize significant amounts of fatty acids. In fact, the small amount of PA taken up, revealed by the [ 14 C]palmitate uptake assay, may possibly exit the cells as would be expected for endothelial transfer of lipid from blood to tissues. Furthermore, attenuating fatty acid uptake does not prevent the effects of PA on monocyte adhesion to and transmigration across the HAMEC monolayer. Thus, mechanisms other than lipid metabolism must be involved in PA-induced activation of proinflammatory responses in microvascular cells.
Saturated fatty acids can activate several signaling pathways. Of particular interest is the activation of TLR4 by PA, which leads to activation of NF-B signaling and expression of inflammatory cytokines (41) . In HUVEC and HAEC, NF-B activation led to increased gene expression of IL-6, IL-8, SELE, ICAM-1, and VCAM-1 (10, 22, 49) , whereas silencing NF-B signaling in dermal microvascular endothelial cells prevented the rise in ICAM-1 expression caused by PA (31) . Consistent with those findings, in the present study we find that the PA-induced ICAM-1 in HAMEC occurs as a consequence of activation of the TLR4¡NF-B signaling pathway.
During tissue infection or damage, inflammation triggers the expression of adhesion molecules and their exposure at the luminal side of endothelial cells to promote leukocyte binding. We demonstrate here that saturated fatty acids can induce the expression and surface exposure of ICAM-1. Interestingly, ICAM-1 transcriptional levels rise in mouse adipose tissue after only 3 wk of high-fat feeding (8) , and notably ICAM-1, SELE, and P-selectin are elevated at the surface of endothelial cells of adipose tissue from obese mice (33) . In the latter study, neutralizing antibodies against ICAM-1 eliminated the rolling and adhesion of leukocytes, indicating that endothelial cells are activated within obese adipose tissue and might play a significant role in the infiltration by immune cells during obesity (33) . Consistent with this finding, ICAM-1 deficiency reduced atherosclerotic lesions in apolipoprotein E knockout mice (7) . Nonetheless, the contribution of ICAM-1 to the macrophage infiltration of adipose tissue in obesity is still under debate. In one study, high-fat-fed Icam1 Ϫ/Ϫ mice showed no changes in fat pad weight or in number of infiltrating macrophages compared with wild-type littermates (37), but high-fat feeding in this mouse model also has variable effects on adiposity (15, 20) . Our observations in HAMEC indicate that PA raises ICAM-1 but not SELE exposure at the cell surface and promotes monocyte transmigration. These results support the idea that ICAM-1 rather than SELE is involved in fatty acidinduced adhesion of leukocytes at the level of the microvasculature. transcytosis of Alexa fluor 568-conjugated insulin was measured by TIRF microscopy as described in METHODS. Data are means Ϯ SE; n ϭ 3. **P Ͻ 0.01. B: transcytosis of biotinylated insulin was measured in a transwell assay as described in METHODS. Data are means Ϯ SE; n ϭ 3. *P Ͻ 0.05. C: uptake of FITC-tagged insulin was measured by confocal microscopy as described in METHODS. Data are means Ϯ SE; n ϭ 3. *P Ͻ 0.05. D: HAMEC were incubated for 18 h with PA in the presence of TLR4 inhibitor TAK242 (200 M). Insulin transcytosis was measured by TIRF microscopy. Data are means Ϯ SE; n ϭ 3. *P Ͻ 0.05. E: TLR4 was knocked down using siRNA, and insulin transcytosis was measured by TIRF microscopy. Data are means Ϯ SE; n ϭ 3. *P Ͻ 0.05.
Another major contribution of the microvasculature to metabolic diseases is its function as a barrier between circulating insulin and its target tissues. Key physiological studies have indeed shown that transfer across the endothelium is a ratelimiting step in insulin availability and its metabolic action (13, 28) . Obese subjects have higher lymph insulin concentrations reflecting the muscle interstitial space levels (11) , and in dogs fed a high-fat diet, there was a further delay in the time that injected insulin reached the interstitial space (27) . These important findings suggest that profound modifications of the vasculature physiology take place during obesity.
In the present study, we demonstrate that insulin transcytosis is impaired by PA but not by PO. Because PA can cause insulin resistance in metabolically relevant cells, we investigated whether the PA inhibition of insulin transcytosis in HAMEC would also involve elements of insulin action. Surprisingly, insulin transcytosis in HAMEC was not affected by silencing either the insulin or the IGF-I receptor (results not shown). Future work will explore the nature of the receptors mediating insulin uptake into microvascular endothelial cells leading to transcytosis, a process we recently reported to occur through clathrin-mediated endocytosis (4) . Of course, the PA-provoked inhibition of insulin transcytosis reported herein may reflect a susceptibility of microvessels to circulating saturated fats, which may contribute to whole body insulin resistance by reducing or delaying insulin delivery to metabolic tissues.
Interestingly, and similarly to the binding of monocytes, the impairment of insulin transcytosis by PA also depends on the activation of cell autonomous proinflammatory pathways, as it was prevented by inhibiting or silencing TLR4. Our findings open new perspectives to decipher the mechanisms involved and identify targets to restore insulin transit. The PAinduced reduction in insulin transcytosis across HAMEC suggests the possibility that functional alterations may occur at the level of the microvasculature during the metabolic syndrome, in addition to the well-documented defects in large vessel vasodilation (25) .
In conclusion, using physiologically relevant microvascular cells in culture, we demonstrate that HAMEC mount an inflammatory response to palmitate that impairs insulin traffic while promoting monocyte binding and transmigration. These findings have relevant implications for diabetes and the metabolic syndrome and suggest that endothelial cells could potentially constitute a novel therapeutic target to taper tissue inflammation and restore insulin sensitivity.
